19/06/19 - Barcelona Biotech Breakfast: Applying AI in Drug Discovery and Drug Development
Our CEO, Raja Sharif, will be joining the panel to talk about Clinical applications of AI in drug discovery and development on Wednesday 19th June.
About the event
Machine learning and other technologies are expected to make the hunt for new pharmaceuticals quicker, cheaper and more effective. In today's digital economy, digitisation has become a vital way to build competitive differentiation in an encreasingly competitive market. Artificial intelligence has a projected market value in drug discovery expected to reach $4 billion by 2024.
This DIT Barcelona Biotech Breakfast will take place at the Parc Cientific de Barcelona on Wednesday 19th June 2019. The event will include masterclasses in an open panel discussion format with leading British and Catalan speakers sharing their knowledge of artificial intelligence in drug discovery and development. There will be networking opportunities where you can meet the experts and ask any questions. The DIT Barcelona team are also happy to organise one to one meetings for any attendees with the UK companies and organisations.
Full programme of speakers to be published and the events page and sent to registered attendees to follow shortly.
Attendance to the event is free but seats are limited, so register now to reserve your place!
Wednesday, 19 June 2019
Networking with refreshments08:30 - 09:00
Registration09:00 - 09:10
Opening speeches Maria Terrades, General Director, Parc Cientific de Barcelona Chris Doherty, Managing Director, Alderley Park 09:10 - 10:25
Panel discussion 1 - Pre-clinical applications of AI in drug discovery and development Moderator: Dr Edward Pyzer-Knapp, Dr and Visiting Professor of Industrially Applied AI, University of Liverpool, IBM Enric Herrero, CTO, Pharmacelera Jascha Blobel, CEO, Molomics Anthony Bashall, Director, Zenzium Satnam Surae, Chief Product Officer, Aigenpulse David Bunton, CEO, Reprocell 10:25 - 11:45
Panel discussion 2 - Clinical applications of AI in drug discovery and development Moderator: Cristian Martí, Founder, Methinks John Overington, Professor, Medicines Discovery Catapult Javier de la Oca, CEO, IOMED Professor Manuel Salto-Tellez, Lead of Queen's Medicine Centre of Excellence and Professor of Molecular Pathology , Queen's Univeristy Belfast Euan Cameron, CEO and Founder, Cohesion Medical Raja Sharif, CEO, Farmatrust John McCrae, Chief Technology Officer , North West EHealth (NWEH) 11:45
Closing remarks UK Department for International Trade (DIT)
12:30 End of session